Skip to main content
. 2017 May 29;8(29):48110–48125. doi: 10.18632/oncotarget.18262

Figure 6. The prognostic significance of YB-1 and MACC1 for lung adenocarcinoma patients assessed via Kaplan-Meier analysis.

Figure 6

(A) The expression of YB-1 and MACC1 in lung adenocarcinoma specimens (n=179) was detected by IHC assay. Original magnification 200× and 400× in inset. The overall 5-year survival rates in the patients with low YB-1 expression and high YB-1 expression were 82% and 53%, respectively (p=0.004). Survival curves of low and high expression of YB-1 (B) and MACC1 (C). For each cohort, different subgroups were plotted according to the cutoff values of YB-1 and MACC1, which were defined as the median of the cohort.